| Target Price | $70.89 |
| Price | $48.40 |
| Potential |
46.47%
register free of charge
|
| Number of Estimates | 6 |
|
6 Analysts have issued a price target Ingevity Corporation 2026 .
The average Ingevity Corporation target price is $70.89.
This is
46.47%
register free of charge
$74.55
54.03%
register free of charge
$52.52
8.51%
register free of charge
|
|
| A rating was issued by 10 analysts: 8 Analysts recommend Ingevity Corporation to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Ingevity Corporation stock has an average upside potential 2026 of
46.47%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 1.41 | 1.30 |
| 16.88% | 7.49% | |
| EBITDA Margin | 21.12% | 31.11% |
| 19.47% | 47.32% | |
| Net Margin | -30.60% | 12.67% |
| 9,487.27% | 141.41% |
6 Analysts have issued a sales forecast Ingevity Corporation 2025 . The average Ingevity Corporation sales estimate is
This results in the following potential growth metrics:
6 Analysts have issued an Ingevity Corporation EBITDA forecast 2025. The average Ingevity Corporation EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
6 Ingevity Corporation Analysts have issued a net profit forecast 2025. The average Ingevity Corporation net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -11.85 | 4.52 |
| 7,800.00% | 138.14% | |
| P/E | 10.22 | |
| EV/Sales | 2.26 |
6 Analysts have issued a Ingevity Corporation forecast for earnings per share. The average Ingevity Corporation EPS is
This results in the following potential growth metrics and future valuations:
Ingevity Corporation...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BMO Capital |
Locked
➜
Locked
|
Locked | Sep 05 2025 |
| BMO Capital |
Locked
➜
Locked
|
Locked | Aug 07 2025 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Jul 14 2025 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | May 07 2025 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Apr 09 2025 |
| BMO Capital |
Locked
➜
Locked
|
Locked | Feb 26 2025 |
| BMO Capital |
Locked
➜
Locked
|
Locked | Feb 20 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
BMO Capital:
Locked
➜
Locked
|
Sep 05 2025 |
|
Locked
BMO Capital:
Locked
➜
Locked
|
Aug 07 2025 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Jul 14 2025 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
May 07 2025 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Apr 09 2025 |
|
Locked
BMO Capital:
Locked
➜
Locked
|
Feb 26 2025 |
|
Locked
BMO Capital:
Locked
➜
Locked
|
Feb 20 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


